Cystic fibrosis is a genetic disease that results in progressive multi-organ manifestations with
predominance in the respiratory and gastrointestinal systems. The significant morbidity and …

Bacteriophages infect and replicate within bacteria and play a key role in the environment,
particularly in microbial ecosystems and bacterial population dynamics. The increasing …

As one of the most common pathogens of opportunistic and hospital-acquired infections,
Pseudomonas aeruginosa is associated with resistance to diverse antibiotics, which …

Bacteriophage therapy is a promising strategy used to treat antimicrobial-resistant or
persistent bacterial infections. More recently, the clinical utility of bacteriophages has been …

Patients with cystic fibrosis (CF) are prone to developing life-threatening lung infections with
a variety of pathogens that are difficult to eradicate, such as Burkholderia cepacia complex …

The rise in the frequency of antibiotic resistance has made bacterial infections, specifically
Pseudomonas aeruginosa, a cause for greater concern. Phage therapy is a promising …

Cystic fibrosis (CF) is an inherited disease that results from mutations in the gene
responsible for the cystic fibrosis transmembrane conductance regulator (CFTR). The …

Phage Therapy: An Alternative Approach to Combat Multi-drug Resistant Infections in Cystic
Fibrosis Page 1 Review Not peer-reviewed version Phage Therapy: An Alternative Approach …

Abstract Background and Aim: The use of bioengineered nanocomposites as antimicrobials
has increased in recent years, but very few investigations have been conducted to test their …